IN THE SPOTLIGHT

Camrelizumab Plus Carboplatin, Nab-Paclitaxel Shows Efficacy in ES-SCLC

Camrelizumab Plus Carboplatin, Nab-Paclitaxel Shows Efficacy in ES-SCLC

Can Maintenance Therapy Help Extend Response in Extensive-Stage Small Cell Lung Cancer?

Can Maintenance Therapy Help Extend Response in Extensive-Stage Small Cell Lung Cancer?

New Strategy for Small Cell Lung Cancer Treatment Emerges

New Strategy for Small Cell Lung Cancer Treatment Emerges

New Strategy for Small Cell Lung Cancer Treatment Emerges

New Strategy for Small Cell Lung Cancer Treatment Emerges

Serplulimab Plus Chemotherapy Improves OS and PFS in Older ES-SCLC Populations

Serplulimab Plus Chemotherapy Improves OS and PFS in Older ES-SCLC Populations

Lungcast: Current Perspectives on Treatment of Small Cell Lung Cancer with Jacob Sands, MD

Lungcast: Current Perspectives on Treatment of Small Cell Lung Cancer with Jacob Sands, MD

Lungcast: Current Perspectives on Treatment of Small Cell Lung Cancer with Jacob Sands, MD

Lungcast: Current Perspectives on Treatment of Small Cell Lung Cancer with Jacob Sands, MD

Lungcast: Current Perspectives on Treatment of Small Cell Lung Cancer with Jacob Sands, MD; This episode of Lungcast features a discussion on emerging treatment approaches...

Lungcast: Current Perspectives on Treatment of Small Cell Lung Cancer with Jacob Sands, MD; This episode of Lungcast features a discussion on emerging treatment approaches...

Royalty Pharma to pay up to $950 million for royalties from Amgen's lung cancer drug

Royalty Pharma to pay up to $950 million for royalties from Amgen's lung cancer drug

Clinical Trial: An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

Clinical Trial: An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing